skip to Main Content

News

Istari Oncology Hires Marc Banjak as General Counsel and Secretary as the Company Prepares for a Critical Period of Development and Expansion

Istari Oncology Hires Marc Banjak as General Counsel and Secretary as the Company Prepares for…

read more

Istari Oncology Announces Publication of Phase 1 Data Showing PVSRIPO Immunotherapy Leads to Objective Responses in Patients with Treatment-Refractory Melanoma

Istari Oncology Announces Publication of Phase 1 Data Showing PVSRIPO Immunotherapy Leads to Objective Responses…

read more

Istari Oncology Announces FDA Clearance of IND to Initiate LUMINOS-103

Istari Oncology Announces FDA Clearance of IND to Initiate LUMINOS-103: A Basket Trial Evaluating the…

read more

Istari Oncology Abstracts to be Presented at the American Association for Cancer Research 2021 Annual Meeting

Istari Oncology Abstracts to be Presented at the American Association for Cancer Research (AACR) 2021…

read more

Istari Oncology Announces First Patient Dosed in the LUMINOS-102 Phase 2 Clinical Trial of PVSRIPO

Istari Oncology Announces First Patient Dosed in the LUMINOS-102 Phase 2 Clinical Trial of PVSRIPO…

read more

Published Research in Nature Communications: PVSRIPO Leads to Robust, Functional T Cells — Critical for Antitumor Immunity

Istari Oncology Announces Publication of Data Showing the Investigational Immunotherapy PVSRIPO Leads to Robust, Functional…

read more

Partner News: UConn Health Opens New Cancer Trial with PVSRIPO

From the office of UConn Health: High-Profile Brain Tumor Trial Chooses UConn Health An immunotherapy…

read more

Press Release: FDA Grants Orphan Drug Designation for PVSRIPO for the Treatment of Advanced Melanoma

Istari Oncology Announces FDA Grants Orphan Drug Designation for PVSRIPO for the Treatment of Advanced…

read more

Press Release: Istari Announces 1st Patient in LUMINOS-101 Trial of PVSRIPO with Pembrolizumab for rGBM

Istari Oncology Announces First Patient Dosed in the LUMINOS-101 Phase 2 Clinical Trial of PVSRIPO…

read more

Partner News: UH Seidman Cancer Center Opens New Trial with PVSRIPO

From the office of University Hospitals Seidman Cancer Center: UH Seidman Cancer Center Opens New…

read more
Back To Top
×Close search
Search